HomeCompareDTSOF vs MRK

DTSOF vs MRK: Dividend Comparison 2026

DTSOF yields 7.70% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DTSOF wins by $80877.34M in total portfolio value
10 years
DTSOF
DTSOF
● Live price
7.70%
Share price
$7.99
Annual div
$0.62
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$80877.40M
Annual income
$78,909,387,675.40
Full DTSOF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — DTSOF vs MRK

📍 DTSOF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodDTSOFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, DTSOF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
DTSOF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

DTSOF
Annual income on $10K today (after 15% tax)
$654.72/yr
After 10yr DRIP, annual income (after tax)
$67,072,979,524.09/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, DTSOF beats the other by $67,072,970,927.38/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of DTSOF + MRK for your $10,000?

DTSOF: 50%MRK: 50%
100% MRK50/50100% DTSOF
Portfolio after 10yr
$40438.73M
Annual income
$39,454,698,894.59/yr
Blended yield
97.57%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

DTSOF
No analyst data
Altman Z
10.9
Piotroski
6/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

DTSOF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricDTSOFMRK
Forward yield7.70%2.81%
Annual dividend / share$0.62$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$80877.40M$57.7K
Annual income after 10y$78,909,387,675.40$10,113.78
Total dividends collected$80742.81M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: DTSOF vs MRK ($10,000, DRIP)

YearDTSOF PortfolioDTSOF Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$12,241$1,540.53$11,213$373.04+$1.0KDTSOF
2$16,622$3,524.64$12,667$512.06+$4.0KDTSOF
3$26,732$8,946.33$14,439$708.14+$12.3KDTSOF
4$55,496$26,892.86$16,640$988.16+$38.9KDTSOF
5$163,736$104,355.47$19,432$1,394.07+$144.3KDTSOF
6$750,697$575,499.06$23,057$1,992.90+$727.6KDTSOF
7$5,735,106$4,931,860.40$27,889$2,894.79+$5.71MDTSOF
8$76,562,706$70,426,143.08$34,518$4,286.29+$76.53MDTSOF
9$1,839,262,752$1,757,340,656.00$43,912$6,494.35+$1839.22MDTSOF
10$80,877,398,820$78,909,387,675.40$57,714$10,113.78+$80877.34MDTSOF

DTSOF vs MRK: Complete Analysis 2026

DTSOFStock

DTS Corporation provides systems integration services in Japan. The company operates through four segments: Finance and Society; Corporate Solutions; Operational Infrastructure BPO; and Regional, Overseas, Etc. It develops and maintains information systems; designs and constructs electrical and telecommunications construction work related to information systems; develops, sells, and leases educational equipment and teaching materials related to the information systems; and publishes, edits, and translates work related to the information systems. The company also installs, operates, and maintains computer systems and networks; manufactures, develops, sells, and leases information related equipment comprising computers and software; processes and provides information and commercial transactions; produces, sells, and leases multimedia related content; and acquires, develops, licenses, manages, and transfers intellectual property, such as copyrights and know-how. In addition, it engages in worker dispatch business; and contracting for planning, investigating, researching, training, educating, and consulting activities related to information systems. Further, the company offers enterprise resource planning solutions; and network integration services. It serves finance, telecommunications, and public sector comprising medical welfare, pension authorities, and local governments. DTS Corporation was incorporated in 1972 and is headquartered in Tokyo, Japan.

Full DTSOF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this DTSOF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

DTSOF vs SCHDDTSOF vs JEPIDTSOF vs ODTSOF vs KODTSOF vs MAINDTSOF vs JNJDTSOF vs ABBVDTSOF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.